Drosophila melanogaster: A first step and a stepping-stone to anti-infectives

Current Opinion in Pharmacology

Volumn 13, Issue 5, 2013, Pages 763-768

  Tzelepis, Ilias ^a   Kapsetaki, Stefania Elisavet ^a   Panayidou, Stavria ^b   Apidianakis, Yiorgos ^b  

^a UNIVERSITY OF CRETE   (Greece)

^b UNIVERSITY OF CYPRUS   (Cyprus)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ANTIINFECTIVE AGENT; DEFEROXAMINE; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; TERBINAFINE; VORICONAZOLE;

ARTICLE; BACTERIAL VIRULENCE; CAENORHABDITIS ELEGANS; DROSOPHILA MELANOGASTER; DRUG SCREENING; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; IMMUNE RESPONSE; MYCOBACTERIOSIS; MYCOBACTERIUM MARINUM; NONHUMAN; PHAGOCYTOSIS; PLASMA CELL; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RNA INTERFERENCE; SINDBIS VIRUS; VESICULAR STOMATITIS VIRUS; VIRUS INFECTION; ZYGOMYCETES;

ANIMALS; ANTI-INFECTIVE AGENTS; BACTERIAL INFECTIONS; DISEASE MODELS, ANIMAL; DROSOPHILA MELANOGASTER; DRUG EVALUATION, PRECLINICAL; HUMANS; MYCOSES; VIRUS DISEASES;

EID: 84893000753     PISSN: 14714892     EISSN: 14714973     Source Type: Journal    
DOI: 10.1016/j.coph.2013.08.003     Document Type: Review

References (49)

1. Butler MS, Cooper MA: Antibiotics in the clinical pipeline in 2011. J Antibiotics 2011, 64: 413-425.
2. Apidianakis Y, Rahme LG: Drosophila melanogaster as a model for human intestinal infection and pathology. Dis Models Mech 2011, 4: 21-30.
3. ThoméS, Bizarro CR, Lehmann M, de Abreu BR, de Andrade HH, Cunha KS, Dihl RR: Recombinagenic and mutagenic activities of fluoroquinolones in Drosophila melanogaster. Mutat Res 2012, 742: 43-47.
4. Kislukhin G, Murphy ML, Jafari M, Long AD: Chemotherapy- induced toxicity is highly heritable in Drosophila melanogaster. Pharmacogenet Genomics 2012, 22: 285-289.
5. Pandey UB, Nichols CD: Human disease models in Drosophila melanogaster and the role of the fly in therapeutic drug discovery. Pharmacol Rev 2011, 63: 411-436.
6. Hughes TT, Allen AL, Bardin JE, Christian MN, Daimon K, Dozier KD, Hansen CL, Holcomb LM, Ahlander J: Drosophila as a genetic model for studying pathogenic human viruses. Virology 2012, 423: 1-5.
7. Apidianakis Y, Rahme LG: Drosophila melanogaster as a model host for studying Pseudomonas aeruginosa infection. Nat Protoc 2009, 4: 1285-1294.
8. Kesarwani M, Hazan R, He J, Que Y, Apidianakis Y, Lesic B, Xiao G, Dekimpe V, Milot S, Deziel E, Lépine F, Rahme LG: A quorum sensing regulated small volatile molecule reduces acute virulence and promotes chronic infection phenotypes. PLoS Pathog 2011, 7:e1002192.
9. Inamdar AA, Zaman T, Morath SU, Pu DC, Bennett JW: Drosophila melanogaster as a model to characterize fungal volatile organic compounds. Environ Toxicol 2012 http://dx.doi.org/10.1002/tox.21825.
10. Rera M, Clark RI, Walker DW: Intestinal barrier dysfunction links metabolic and inflammatory markers of aging to death in Drosophila. Proc Natl Acad Sci U S A 2012, 109: 21528-21533.
11. Reiter LT, Potocki L, Chien S, Gribskov M, Bier E: A systematic analysis of human disease-associated gene sequences in Drosophila melanogaster. Genome Res 2001, 6: 1114-1125. (Pubitemid 32834555)
12. Vogel H, Altincicek B, Glöckner G, Vilcinskas A: A comprehensive transcriptome and immune-gene repertoire of the lepidopteran model host Galleria mellonella. BMC Genomics 2011, 12:308.
13. Lionakis M: Drosophila and Galleria insect model hosts. New tools for the study of fungal virulence, pharmacology and immunology. Virulence 2011, 2: 521-527.
14. Hao L, Sakurai A, Watanabe T, Sorensen E, Nidom CA, Newton MA, Ahlquist P, Kawaoka Y: Drosophila RNAi screen identifies host genes important for influenza virus replication. Nature 2008, 454: 890-893.
15. Sessions OM, Barrows NJ, Souza-Neto JA, Robinson TJ, Hershey CL, Rodgers MA, Ramirez JL, Dimopoulos G, Yang PL, Pearson JL, Garcia-Blanco MA: Discovery of insect and human dengue virus host factors. Nature 2009, 458: 1047-1050.
16. Cronin SJ, Nehme NT, Limmer S, Liegeois S, Pospisilik JA, Schramek D et al.: Genome-wide RNAi screen identifies genes involved in intestinal pathogenic bacterial infection. Science 2009, 325: 340-343.
17. Apidianakis Y, Pitsouli C, Perrimon N, Rahme L: Synergy between bacterial infection and genetic predisposition in intestinal dysplasia. Proc Natl Acad Sci U S A 2009, 106: 20883-20888.
18. Jiang H, Patel PH, Kohlmaier A, Grenley MO, McEwen DG, Edgar BA: Cytokine/Jak/Stat signaling mediates regeneration and homeostasis in the Drosophila midgut. Cell 2009, 137: 1343-1355.
19. Rajan A, Perrimon N: Drosophila cytokine unpaired 2 regulates physiological homeostasis by remotely controlling insulin secretion. Cell 2013, 152:1197.
20. Wu SC, Liao CW, Pan RL, Juang JL: Infection-induced intestinal oxidative stress triggers organ-to-organ immunological communication in Drosophila. Cell Host Microbe 2012, 11: 410-417.
21. Ulvila J, Vanha-Aho LM, Rämet M: Drosophila phagocytosis - still many unknowns under the surface. APMIS 2011, 119: 651-662.
22. Apidianakis Y, Mindrinos MN, Xiao W, Tegos GP, Papisov MI, Hamblin MR, Davis RW, Tompkins RG, Rahme LG: Involvement of skeletal muscle gene regulatory network in susceptibility to wound infection following trauma. PLoS ONE 2007, 2:e1356.
23. Wagner C, Isermann K, Fehrenbach H, Roeder T: Molecular architecture of the fruit fly's airway epithelial immune system. BMC Genomics 2008, 9:446.
24. Denholm B, Skaer H: Bringing together components of the fly renal system. Curr Opin Genet Dev 2009, 19: 526-532.
25. Verma P, Tapadia MG: Immune response and anti-microbial peptides expression in Malpighian tubules of Drosophila melanogaster is under developmental regulation. PLoS ONE 2012, 7:e40714.
26. Apidianakis Y, Que YA, Xu W, Tegos GP, Zimniak P, Hamblin MR, Tompkins RG, Xiao W, Rahme LG: Down-regulation of glutatione S-transferase a4 (hGSTA4) in the muscle of thermally injured patients is indicative of susceptibility to bacterial infection. FASEB J 2012, 26: 730-737.
27. Panayidou S, Apidianakis Y: Regenerative inflammation: lessons from Drosophila intestinal epithelium in health and disease. Pathogens 2013, 2: 209-231.
28. Bronkhorst AW, van Cleef KW, Vodovar N, Ince IA, Blanc H, Vlak JM, Saleh MC, van Rij RP: The DNA virus invertebrate iridescent virus 6 is a target of the Drosophila RNAi machinery. Proc Natl Acad Sci U S A 2012, 109:E3604-E3613.
29. Oh CT, Moon C, Choi TH, Kim BS, Jang J: Mycobacterium marinum infection in Drosophila melanogaster for antimycobacterial activity assessment. J Antimicrob Chemother 2013, 68: 601-609.
30. Kim JJ, Lee HM, Shin DM, Kim W, Yuk JM, Jin HS, Lee SH, Cha GH, Kim JM, Lee ZW, Shin SJ et al.: Host cell autophagy activated by antibiotics is required for their effective antimycobacterial drug action. Cell Host Microbe 2012, 11: 457-468.
31. Bangi E, Pitsouli C, Rahme LG, Cagan R, Apidianakis Y: Immune response to bacteria induces dissemination of Ras-activated Drosophila hindgut cells. EMBO Rep 2012, 13: 569-576.
32. Christofi T, Apidianakis Y: Ras-oncogenic Drosophila hindgut but not midgut cells use an inflammation-like program to disseminate to distant sites. Gut Microbes 2013, 4: 1-6.
33. Heo YJ, Lee YR, Jung HH, Lee JE, Ko GP, Cho YH: Antibacterial efficacy of phages against Pseudomonas aeruginosa infections in mice and Drosophila melanogaster. Antimicrob Agents Chemother 2009, 53: 2469-2474.
34. Chung IY, Sim N, Cho YH: Antibacterial efficacy of temperate phage-mediated inhibition of bacterial group motilities. Antimicrob Agents Chemother 2012, 56: 5612-5617.
35. Lionakis MS, Kontoyiannis DP: Drosophila melanogaster as a model organism for invasive aspergillosis. Methods Mol Biol 2012, 845: 455-468.
36. Chamilos G, Lewis RE, Hu J, Xiao L, Zal T, Gilliet M, Halder G, Kontoyiannis DP: Drosophila melanogaster as a model host to dissect the immunopathogenesis of zygomycosis. Proc Natl Acad Sci U S A 2008, 8: 9367-9372.
37. Lamaris GA, Chamilos G, Lewis RE, Kontoyiannis DP: Virulence studies of Scedosporium and Fusarium species in Drosophila melanogaster. J Infect Dis 2007, 196: 1860-1864. (Pubitemid 351411948)
38. Lionakis MS, Lewis RE, May GS, Wiederhold NP, Albert ND, Halder G, Kontoyiannis DP: Toll-deficient Drosophila flies as a fast, high-throughput model for the study of antifungal drug efficacy against invasive aspergillosis and Aspergillus virulence. J Infect Dis 2005, 191: 1188-1195. (Pubitemid 40404379)
39. Lewis RE, Ben-Ami R, Best L, Albert N, Walsh TJ, Kontoyiannis DP: Tacrolimus enhances the potency of posaconazole against Rhizopus oryzae in vitro and in an experimental model of mucormycosis. J Infect Dis 2013, 207: 834-841.
40. Rose PP, Hanna SL, Spiridigliozzi A, Wannissorn N, Beiting DP, Ross SR, Hardy RW, Bambina SA, Heise MT, Cherry S: Natural resistance-associated macrophage protein is a cellular receptor for sindbis virus in both insect and mammalian hosts. Cell Host Microbe 2011, 10: 97-104.
41. Nakamoto M, Moy RH, Xu J, Bambina S, Yasunaga A, Shelly SS, Gold B, Cherry S: Virus recognition by Toll-7 activates antiviral autophagy in Drosophila. Immunity 2012, 36: 658-667.
42. Schnettler E, Sterken MG, Leung JY, Metz SW, Geertsema C, Goldbach RW, Vlak JM, Kohl A, Khromykh AA, Pijlman GP: Noncoding flavivirus RNA displays RNA interference suppressor activity in insect and mammalian cells. J Virol 2012, 86: 13486-13500.
43. Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, Nielsen T, Pons N, Levenez F, Yamada T, Mende DR et al.: A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010, 464: 59-65.
44. Christofi T, Apidianakis Y: Drosophila immune priming against Pseudomonas aeruginosa is short-lasting and depends on cellular and humoral immunity. F1000Research 2013, 2:76.
45. Gangloff M, Weber ANR, Gibbard RJ, Gay NJ: Evolutionary relationships, but functional differences, between the Drosophila and human Toll-like receptor families. Biochem Soc Trans 2003, 31: 659-663. (Pubitemid 36750751)
46. Schein CH, Chen D, Ma L, Kanalas JJ, Gao J, Jimenez ME, Sower LE, Walter MA, Gilbertson SR, Peterson JW: Pharmacophore selection and redesign of non-nucleotide inhibitors of anthrax edema factor. Toxins (Basel) 2012, 4: 1288-1300.
47. Kortagere S: Screening for small molecule inhibitors of Toxoplasma gondii. Expert Opin Drug Discov 2012, 7: 1193-1206.
48. Chang S, Bray SM, Li Z, Zarnescu DC, He C, Jin P, Warren ST: Identification of small molecules rescuing fragile X syndrome phenotypes in Drosophila. Nat Chem Biol 2008, 4: 256-263. (Pubitemid 351419125)
49. Nall AH, Sehgal A: Small-molecule screen in adult Drosophila identifies VMAT as a regulator of sleep. J Neurosci 2013, 33: 8534-8540.